login
  Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 




Featured Highlights
11 - 30 of 153   Items
Liver tumour ablation more predictable with Emprint

Liver tumour ablation more predictable with Emprint

Thursday, 17 Jul 2014
Covidien has unveiled an advanced ablation system that offers physicians predictable results regardless of the target location or tissue type. Liver tumour ablation more predictable with Emprint
Pressure-directed embolotherapy using antireflux devices to perform liver directed regional therapy

Pressure-directed embolotherapy using antireflux devices to perform liver directed regional therapy

Tuesday, 08 Jul 2014
Unintended non-target delivery of embolic agents into any of the various hepaticoentric arteries that course from an intrahepatic artery to implant into an extra hepatic organ such as the stomach or small intestine can result in serious complications, especially gastrointestinal ulcerations, particularly with Y-90 microspheres. Now, temporary antireflux devices are available that appear to provide both adequate retrograde and antegrade protection against nontarget delivery of cytotoxic agents, Pressure-directed embolotherapy using antireflux devices to perform liver directed regional therapy

Terumo obtains regulatory approvals for marketing MicroThermX in additional countries

Friday, 27 Jun 2014
BSD Medical Corporation reported that Terumo Europe NV (Terumo) has obtained approvals to market and import the MicroThermX Microwave Ablation System in South Africa, Dubai, Qatar, and Jordan. Terumo obtains regulatory approvals for marketing MicroThermX in additional countries
Three millimetre “ice ball” margin beyond renal tumours adequate for effective cryoablation

Three millimetre “ice ball” margin beyond renal tumours adequate for effective cryoablation

Friday, 13 Jun 2014
The results from a small, animal study challenge previously unsubstantiated published reports claiming that a five to 10mm “ice ball” margin beyond the tumour is necessary for effective cryoablation. Three millimetre “ice ball” margin beyond renal tumours adequate for effective cryoablation

Philips expands interventional oncology portfolio with EmboGuide to see, reach and treat tumour lesions

Friday, 16 May 2014
New live 3D image guidance tool enhances tumour embolization procedures on Philips’ interventional X-ray systems. Philips expands interventional oncology portfolio with EmboGuide to see, reach and treat tumour lesions
Reducing the perils of ablation for thermally sensitive adjacent organs

Reducing the perils of ablation for thermally sensitive adjacent organs

Friday, 16 May 2014
Over the years, we have seen a rapid development of tools, tricks and techniques that enable ablation of tumours located in regions that are in close proximity to thermally sensitive organs or structures, writes Nishita Kothary (Stanford University, USA). Reducing the perils of ablation for thermally sensitive adjacent organs

Surefire system vs. end hole catheter clinical trial eliminates patient variables

Monday, 05 May 2014
Preliminary observations from the trial were presented at the Global Embolization Symposium and Technologies US (GEST US meeting, 1–4 May, San Francisco, USA) and show increased tumour penetration with the Surefire system. Surefire system vs. end hole catheter clinical trial eliminates patient variables
Interventional radiology techniques and results for the management of neuroendocrine liver metastases

Interventional radiology techniques and results for the management of neuroendocrine liver metastases

Wednesday, 30 Apr 2014
Interventional radiology techniques are widely performed and useful in liver metastases from neuroendocrine tumours, but the level of scientific proof is paradoxically low, especially when considering that these techniques are used in patients with cancer, write Maxime Ronot and Valérie Vilgrain Interventional radiology techniques and results for the management of neuroendocrine liver metastases
COSY trial shows highly reduced radioembolization procedure time and radiation dose

COSY trial shows highly reduced radioembolization procedure time and radiation dose

Friday, 28 Mar 2014
Surefire Medical has announced that the COSY clinical trial (Coiling vs. Surefire infusion system in Y90) showed significant reductions in fluoroscopy time, procedure time, radiation dose and contrast dose when using the Surefire Infusion System without coiling. COSY trial shows highly reduced radioembolization procedure time and radiation dose

Sirtex and Guerbet announce collaboration in clinical studies in liver cancer

Thursday, 27 Mar 2014
Sirtex and Guerbet have announced that the two companies are entering into a collaboration to advance research in primary and secondary metastatic liver cancer. Sirtex and Guerbet announce collaboration in clinical studies in liver cancer

Cancer specialists to head to Berlin to attend ECIO

Thursday, 27 Mar 2014
The world’s leading radiologists, oncologists and surgeons will head to Germany in April for the European Conference on International Oncology (ECIO, 23-26 April, Berlin, Germany). Cancer specialists to head to Berlin to attend ECIO
Radioembolization offers new, safe treatment for metastatic breast cancer

Radioembolization offers new, safe treatment for metastatic breast cancer

Monday, 24 Mar 2014
The largest study of its kind to date shows that minimally invasive radioembolization may slow metastatic disease progression in liver when no other treatment options remain, according to research being presented at the Society of Interventional Radiology’s 39th Annual Scientific Meeting (22–27 March, San Diego, USA). Radioembolization offers new, safe treatment for metastatic breast cancer
Safety and efficacy of percutaneous cryoablation in renal cell carcinoma in 2014

Safety and efficacy of percutaneous cryoablation in renal cell carcinoma in 2014

Thursday, 27 Feb 2014
The outcomes from our study on the efficacy and safety of percutaneous cryoablation, published recently in CardioVascular and Interventional Radiology (CVIR), are the result of the most rigorous investigation on the subject to-date. These exceptional numbers, however, are a double-edged sword. On one hand, they approach those of the gold standard, on the other, we must prove they are widely reproducible, writes Christos Georgiades Safety and efficacy of percutaneous cryoablation in renal cell carcinoma in 2014
MORE study data provide insight into predicting SIRT treatment outcomes

MORE study data provide insight into predicting SIRT treatment outcomes

Thursday, 23 Jan 2014
Investigators from the MORE (Metastatic colorectal cancer liver metastases outcomes after radioembolization) study have released new findings at the American Society of Clinical Oncology’s 2014 Gastrointestinal Cancers Symposium confirming that standard laboratory tests are a valuable tool for predicting patient outcomes prior to Selective Internal Radiation Therapy (SIRT). MORE study data provide insight into predicting SIRT treatment outcomes
Cryoablation provides pain relief for patients with metastatic tumours

Cryoablation provides pain relief for patients with metastatic tumours

Sunday, 19 Jan 2014
Cryoablation kills tumours and provides pain relief to patients whose cancer has spread to the bone and soft tissue, suggests research being presented at the 6th annual Symposium on Clinical Interventional Oncology (CIO), in collaboration with the International Symposium on Endovascular Therapy (ISET). Cryoablation provides pain relief for patients with metastatic tumours
Ten-year Spanish experience shows SIRT achieves disease control in over 80% hepatocellular carcinoma patients

Ten-year Spanish experience shows SIRT achieves disease control in over 80% hepatocellular carcinoma patients

Tuesday, 14 Jan 2014
The Clínica Universidad de Navarra (CUN), Pamplona, Spain, recently celebrated its tenth anniversary of using Yttrium-90 (Y-90) microsphere radioembolization for the treatment of liver cancer. Ten-year Spanish experience shows SIRT achieves disease control in over 80% hepatocellular carcinoma patients
Effectiveness of percutaneous cryoablation for stage IA/B renal cell carcinoma approaches that of gold standard, surgery

Effectiveness of percutaneous cryoablation for stage IA/B renal cell carcinoma approaches that of gold standard, surgery

Monday, 13 Jan 2014
A prospective single-arm, five-year study has found that CT-guided percutaneous cryoablation for renal cell carcinoma offers very high efficacy, approaching that of the gold standard, surgery. Cryoablation also has a more favourable safety profile. Effectiveness of percutaneous cryoablation for stage IA/B renal cell carcinoma approaches that of gold standard, surgery

Launch of Hepatic Oncology: a journal dedicated to the management of cancers of the liver

Friday, 10 Jan 2014
Future Medicine Ltd has announced the launch of a new journal, Hepatic Oncology. This new title focuses specifically on the specialism of hepatic cancer, including both primary and secondary malignancies. Launch of Hepatic Oncology: a journal dedicated to the management of cancers of the liver
Interventional oncologists begin running US National Cancer Institute cooperative group trial

Interventional oncologists begin running US National Cancer Institute cooperative group trial

Friday, 20 Dec 2013
An important opportunity has opened up for interventional oncologists as WCIO leaders take the helm of the E1208 trial. Michael C Soulen writes that the change in the trial leadership from medical oncology to interventional oncology represents a challenge because it rests on the question: can interventional oncologists run a successful cooperative group trial of image-guided therapy? Interventional oncologists begin running US National Cancer Institute cooperative group trial
Surefire Medical completes patient enrolment in COSY trial

Surefire Medical completes patient enrolment in COSY trial

Wednesday, 11 Dec 2013
The trial evaluates eliminating coiling by using the anti-reflux Surefire Infusion System in radioembolization procedures in liver cancer. Surefire Medical completes patient enrolment in COSY trial
Found: 153   Displaying: 11-30
Results: 1 2 3 4 5 Next Go to:

Related Section


Clinical Trials
Interventional Oncology News
Interventional Oncology Supplement
Key Opinion Leaders discuss the role of Biocompatible's DC Bead at CIRSE and ILCA
IR Views
Literature
Oncology Useful Links

Related Feeds


Most popular


Live from VEITH 2014: SUPERB results show 94% freedom from reintervention with nominal deployment of Supera at three years
Wednesday, 19 Nov 2014
Three-year follow-up results of patients treated with the Supera stent show that nominal deployment or slight compression of the device delivers the best outcomes in terms of durability, and that ... Live from VEITH 2014: SUPERB results show 94% freedom from reintervention with nominal deployment of Supera at three years

New deep vein thrombosis guidelines: What you need to know
Thursday, 23 Oct 2014
Suresh Vedantham spoke to Interventional News on the latest from the paper “Quality improvement guidelines for the treatment of lower-extremity deep vein thrombosis with use of endovascular thrombus ... New deep vein thrombosis guidelines: What you need to know

Bioresorbable scaffolds can produce comparable acute results to metal stents
Tuesday, 04 Nov 2014
Speaking at the Asian Society for Vascular Surgery meeting (5–7 September, Hong Kong, China), Andrew Holden commented that studies indicate that bioresorbable scaffolds can produce comparable acute ... Bioresorbable scaffolds can produce comparable acute results to metal stents

Features


Stentoplasty: An “exciting frontier” in spinal augmentation
Thursday, 27 Nov 2014
Stentoplasty, or vertebral body stenting, represents the next step in the evolution of cement spinal augmentation where a stent is placed within the vertebral body followed by infusion of cement. Stentoplasty: An “exciting frontier” in spinal augmentation

CO2 angiography should be more widely used
Thursday, 27 Nov 2014
CO2 angiography can decrease both morbidity and mortality for patients, in certain clinical scenarios. For those driven by economics, the cost of 100cc of CO2 is approximately three cents. Its use is ... CO2 angiography should be more widely used

Profiles


Gao-Jun Teng
Thursday, 11 Dec 2014
In the future, will interventional radiology be a subspecialty of radiology, or surgery? asks Gao-J... Gao-Jun Teng

José Ignacio Bilbao Jaureguízar
Wednesday, 08 Oct 2014
“No matter what their future orientation, interventional radiologists involved in interventional ... José Ignacio Bilbao Jaureguízar

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions